A Phase 3 trial investigating a real-time electronic antiretroviral adherence monitoring intervention for HIV reached its primary completion on 2026-02-28, having enrolled 126 participants.

Background

Adherence to antiretroviral therapy (ART) is a critical factor in the effective management of HIV infections. Consistent medication intake helps suppress the viral load, prevent drug resistance, and improve the overall health and longevity of individuals living with HIV. However, maintaining high levels of adherence can be challenging for various reasons, including complex dosing schedules, side effects, and socioeconomic factors. Interventions that support and monitor adherence are therefore vital in optimizing treatment outcomes and public health efforts against HIV.

Trial design

This Phase 3 study, titled "Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention," enrolled 126 participants. The trial focused on individuals with HIV Infections and issues related to Medication Adherence. The intervention involved using an electronic adherence device, a pill container designed to alert users if it is not opened at a scheduled time. It also alerts a pre-identified social support person or case manager if 2 or 7 consecutive days of nonadherence are detected. The approach is referred to as "A-Team" (Antiretroviral Therapy Electronic Adherence Monitoring).

What this means

The primary completion of this Phase 3 trial marks a significant milestone in the development of new tools to support medication adherence for individuals with HIV. While specific efficacy or safety results are not yet available, the completion of this phase indicates that the study has progressed through its main data collection period for its primary objectives. The intervention, which utilizes real-time electronic monitoring and alerts, aims to address a critical challenge in HIV care: consistent adherence to antiretroviral therapy. Future data releases from this trial will be crucial for understanding the potential impact of such technology on patient outcomes and adherence rates.

Source

The information regarding the primary completion of this trial was sourced from ClinicalTrials.gov, a public database of clinical studies. The event was recorded on 2026-02-28 for the study NCT06550804, titled "Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention," on clinicaltrials.gov.